A Pilot Study to Evaluate Neurodevelopmental Outcomes in a Pediatric Cohort With Genodermatoses

Area of Science:

• Dermatology
• Neuroscience
• Genetics

Background:

• Genetic skin disorders can affect various germ layers, including ectoderm, mesoderm, and neuroectoderm.
• Neuroectodermal involvement in genetic skin disorders raises questions about potential neurocognitive implications.
• Understanding the neurodevelopmental impact is crucial for comprehensive patient care.

Purpose of the Study:

• To evaluate and compare cognitive function in individuals with genetic skin disorders involving neuroectoderm versus those with only ectoderm or mesoderm involvement.
• To investigate differences in adaptive skills, behavior, and quality of life (QoL) between these groups.
• To establish a framework for neurocognitive testing in patients with genodermatoses.

Main Methods:

• A prospective, cross-sectional pilot study involving 24 participants.
• Participants were divided into two groups: neuroectodermal involvement (n=8) and ectodermal/mesodermal involvement (n=16).
• Neurodevelopmental tests were used to assess cognition, adaptive skills, behavior, and QoL, with data analyzed using descriptive statistics.

Main Results:

• No statistically significant differences were found in cognitive composite scores, adaptive composite scores, QoL raw scores, or internalizing/externalizing behavior T-scores between the two groups.
• Average age in the neuroectodermal group was 7 years, and in the ectodermal/mesodermal group was 5.9 years.
• The study highlighted the heterogeneity of diagnoses within groups, suggesting a need for larger sample sizes.

Conclusions:

• This pilot study found no significant difference in neurocognitive functioning between individuals with genetic skin disorders involving neuroectoderm and those with ectodermal/mesodermal involvement.
• The findings suggest that neuroectodermal involvement alone may not directly correlate with poorer neurocognitive outcomes in this patient population.
• Larger studies with homogenous diagnoses are required to determine clinical significance and explore effective interventions for neurodevelopmental outcomes in genodermatoses.